Amos Meltzer has over 25 years of experience in international trade, commercialising technologies & life sciences. He has overseen life science research and product development projects as well as clinical trials and the sale & marketing of a pharmaceutical product.
His experience and knowledge is drawn from having worked in law firms (Freehills and K&L Gates) and as in-house counsel and IP director at two Nasdaq-listed companies, as a non-executive director of a biotechnology company, and as vice president of business development and chief executive of ASX-listed biopharmaceutical company Immuron.